Ayşen Işık

Ayşen Işık

Auto-generated profile, based on publicly available information

Ayşen Işık

Selcuk University

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 November 2022 in SAR and QSAR in Environmental Research
Verified
Journal Article
Closed access
UÇUlviye ACAR ÇEVİK
Ulviye ACAR ÇEVİK
AIA. Işık
A. Işık
Asaf Evrim EVRENAsaf Evrim EVREN
Asaf Evrim EVREN
ÖKÖ. Kapusız
Ö. Kapusız
ÜGÜlküye Dudu GÜL
Ülküye Dudu GÜL
ZKZafer Asım Kaplancıklı
Zafer Asım Kaplancıklı
A series of some new benzimidazole-1,3,4-thiadiazoles was synthesized. The structures of target substances were confirmed by using 1H-NMR and 13С-NMR spectroscopy, mass spectrometry and elemental analysis. The synthesized compounds were evaluated for antimicrobial activity against six bacterial strains namely Escherichia coli (ATCC 25922), Klebsiella pneumoniae (ATCC 13883), Pseudomonas aeruginosa (ATCC 27853), Enterococcus faecalis (ATCC 2942), Bacillus subtilis (ATCC 6633), Staphylococcus aureus (ATCC 29213)and four fungal strains namely Candida albicans (ATCC 24433), Candida krusei (ATCC 6258), Candida parapsilosis (ATCC 22019) and Candida glabrata (ATCC 9). Antimicrobial data revealed that compounds 4f and 4i with MIC of < 0.97 µg/mL were found to be most effective against E. coli. Among the studied molecules, compounds 4f and 4i showed the best antifungal activity with MIC value of 1.95 µg/mL. Additionally, docking studies were performed towards the most promising compounds 4f and 4i, in the active site of DNA gyrase revealing strong interactions. A molecular dynamics (MD) simulation analysis was also used to investigate the dynamic nature, binding interaction, and protein–ligand stability.

3 October 2023 in Journal of Molecular Structure
Verified
Journal Article
Closed access
UÇUlviye ACAR ÇEVİK
Ulviye ACAR ÇEVİK
AIAyşen Işık
Ayşen Işık
RKRavikumar Kapavarapu
Ravikumar Kapavarapu
KKKaan Küçükoğlu
Kaan Küçükoğlu
HNHayrunnisa Nadaroglu
Hayrunnisa Nadaroglu
ZKZafer Asım Kaplancıklı
Zafer Asım Kaplancıklı

1 September 2022 in Phosphorus, Sulfur, and Silicon and the Related Elements
Verified
Journal Article
Closed access
UÇUlviye ACAR ÇEVİK
Ulviye ACAR ÇEVİK
ICIsmail Celik
Ismail Celik
AIAyşen Işık
Ayşen Işık
ÜGÜlküye Dudu Gül
Ülküye Dudu Gül
GBGizem Bayazıt
Gizem Bayazıt
ZKZafer Asım Kaplancıklı
Zafer Asım Kaplancıklı
A series of novel tetrazole-S-alkyl-piperazine derivatives were synthesized and evaluated for their antifungal activity against C. albicans (ATCC 24433), C. krusei (ATCC 6258) and C. parapsilosis (ATCC 22019) and antibacterial activity against E. coli (ATCC 25922), S. marcescens (ATCC 8100), K. pneumoniae (ATCC 13883), P. aeruginosa (ATCC 27853), E. faecalis (ATCC 2942), B. subtilis (ATCC), S. aureus (ATCC 29213), S. epidermidis (ATCC 12228). Among the synthesized compounds, 1-(4-cycylohexylpiperazin-1-yl)-2-((1-methyl-1H-tetrazol-5-yl)thio)ethan-1-one (2b) (MIC = 7.81 µg/mL) and 1-(4-(4-chlorobenzyl)piperazin-1-yl)-2-((1-methyl-1H-tetrazol-5-yl)thio)ethan-1-one (2f) (MIC = 3.90 µg/mL) displayed significant antifungal activity and compared to reference drugs voriconazole and fluconazole. Besides, compound 2b has showed also higher antibacterial activity against E. faecalis (ATCC 2942) as a reference drug azithromycin, with a MIC value of 3.90 µg/mL, and compound 2d was found to be effective against S. epidermidis (ATCC 12228) as the same reference drug, with a MIC value of 7.81 µg/mL. All the derivatives were efficiently synthesized by a two-step process. The structure of the newly synthesized compounds was elucidated by their 1H NMR, 13C NMR, LC-MS/MS, and elemental analysis. In this study, the detailed synthesis, spectroscopic and biological evaluation data are reported. Molecular docking studies of all compounds were performed with the sterol 14-alpha demethylase enzyme of C. albicans, the target enzyme of azole antifungal drugs. Graphical Abstract

1 June 2023 in Medicinal Chemistry
Verified
Journal Article
Open access
PDF file
KKKaan Küçükoğlu
Kaan Küçükoğlu
UÇUlviye ACAR ÇEVİK
Ulviye ACAR ÇEVİK
HNHayrunnisa Nadaroglu
Hayrunnisa Nadaroglu
ICIsmail Celik
Ismail Celik
AIAyşen Işık
Ayşen Işık
ZKZafer Asım Kaplancıklı
Zafer Asım Kaplancıklı
Background: The carbonic anhydrases (CAs) which are found in most living organisms is a member of the zinc-containing metalloenzyme family. The abnormal levels and activities are frequently associated with various diseases therefore CAs have become an attractive target for the design of inhibitors or activators that can be used in the treatment of those diseases. Methods: Herein, we have designed and synthesized new benzimidazole-hydrazone derivatives to investigate the effects of these synthesized compounds on CA isoenzymes. Chemical structures of synthesized compounds were confirmed by 1H NMR, 13C NMR, and HRMS. The synthetic derivatives were screened for their inhibitory potential against carbonic anhydrase I and II by in vitro assay. Results: These compounds have IC50 values of 5.156-1.684 μM (hCA I) and 4.334-2.188 μM (hCA II). Inhibition types and Ki values of the compounds were determined. The Ki values of the compounds were 5.44 ± 0.14 μM-0.299 ± 0.01 μM (hCA I) and 3.699 ± 0.041 μM-1.507 ± 0.01 μM (hCA II). The synthetic compounds displayed inhibitory action comparable to that of the clinically utilized reference substance, acetazolamide. According to this, compound 3p was the most effective molecule with an IC50 value of 1.684 μM. Accordingly, the type of inhibition was noncompetitive and the Ki value was 0.299 ± 0.01 μM. Conclusion: According to the in vitro test results, detailed protein-ligand interactions of the compound 3p, which is more active against hCA I than standard azithromycin (AZM), were analyzed. In addition, the cytotoxic effects of the compounds on the L929 healthy cell line were evaluated.

5 November 2025 in Chemistry & Biodiversity
Verified
Journal Article
Closed access
AIAyşen Işik
Ayşen Işik
UÇUlviye Acar Çevik
Ulviye Acar Çevik

27 December 2022 in Cumhuriyet Science Journal
Verified
Journal Article
Open access
PDF file
AIAyşen IŞIK
Ayşen IŞIK
KCKezban Ucar Cifci
Kezban Ucar Cifci
HBHayrani Eren Bostancı
Hayrani Eren Bostancı
YTYusuf Tutar
Yusuf Tutar
AKAhmet Koçak
Ahmet Koçak
MYMustafa Yilmaz
Mustafa Yilmaz
In this study, four stages were used to create brand-new p-tert-butyl-calix [4] arene Schiff base derivatives. First, p-tert-butyl-phenol and formaldehyde are reacted to create p-tert-butyl-calix [4] arene (1). In the following step, methyl bromoacetate and p-ter-butyl-calix [4] arene (1) were combined with acetone and reflux to create the p-tert-butyl-calix [4] arene diester complex (2). The third step involves reacting the diester compound (2) and hydrazine hydrate to create the p-tert-butyl-calix [4] arene hydrazinamide molecule (3). In the final stage, calix [4] arene Schiff base derivatives (4a-d) were produced in good yields by combining compound (3), p-tert-butyl-calix [4] arene hydrazinamide, and various aldehyde derivatives with reflux in EtOH. Through the use of 1H-NMR, 13C-NMR, infrared spectroscopy, and elemental analysis, the structures of produced compounds were verified. Four distinct cancer lines are linked to the antitumor activity of synthetic chemicals. (HT-29, a human colon cancer cell line, PC-3, a human prostate cancer cell line, C6, a rat glioma cell line and MCF-7, a human breast cancer cell line). Weak antitumor activity was seen in synthetic substances. However, only compound 4b was found to have potential efficacy against C6 and HT-29. It is clear that compound 4b, which has a nitro substitute on the phenyl ring, draws attention due to its increased activity.